Company Name | Total Employees |
---|---|
Walgreens Boots Alliance, Inc. | 206000 |
Rite Aid Corporation | 47000 |
High Tide Inc. | 1550 |
111, Inc. | 1520 |
China Jo-Jo Drugstores, Inc. | 939 |
BIMI International Medical Inc. | 296 |
PetMed Express, Inc. | 287 |
MedAvail Holdings, Inc. | 279 |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 217 |
LifeMD, Inc. | 207 |
Leafly Holdings, Inc. | 121 |
TRxADE HEALTH, Inc. | 8 |
Unveiling the hidden dimensions of data
The pharmaceutical industry has always been a cornerstone of global healthcare, and understanding the workforce behind these giants provides valuable insights into their operational scale. This analysis focuses on the number of employees in the top 10 pharma companies, revealing some fascinating trends.
The data reveals a stark contrast in workforce sizes, with the top two companies employing over 90% of the total workforce among the top 10. This disparity underscores the varying scales at which these companies operate, from global giants to niche players.
The pharmaceutical industry is characterized by a few dominant players with massive workforces and several smaller companies with more specialized operations. This workforce analysis not only highlights the industry's diversity but also provides a glimpse into the operational scales of these leading companies.
5 Year Trend in Average Market Capitalization for AbbVie
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
Average Market Capitalization of Abbvie Annually
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Pharma Companies
5 Year Trend in Average Market Capitalization for AbbVie
5 Year Trend in Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Number of Employees for Top 10 Healthcare Companies
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters